Graphene oxide enhances alginate encapsulated cells viability and functionality while not affecting the foreign body response

References

• Anderson JM, Rodriguez A, Chang DT. (2008). Foreign body reaction to biomaterials. Semin Immunol 20:86–100.
   PubMed Web of Science ®Google Scholar
• Bartholomew A, Sturgeon C, Siatskas M, et al. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42–8.
   PubMed Web of Science ®Google Scholar
• Beckermann BM, Kallifatidis G, Groth A, et al. (2008). VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer 99:622–31.
   PubMed Web of Science ®Google Scholar
• Canibano-Hernandez A, Saenz Del Burgo L, Espona-Noguera A, et al. (2017). Alginate microcapsules incorporating hyaluronic acid recreate closer in vivo environment for mesenchymal stem cells. Mol Pharmaceut 14:2390–9.
   PubMed Web of Science ®Google Scholar
• Cedervall T, Lynch I, Lindman S, et al. (2007). Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 104:2050–5.
   PubMed Web of Science ®Google Scholar
• Ciriza J, Saenz Del Burgo L, Virumbrales-Munoz M, et al. (2015). Graphene oxide increases the viability of C2C12 myoblasts microencapsulated in alginate. Int J Pharm 493:260–70.
   PubMed Web of Science ®Google Scholar
• Dell'orco D, Lundqvist M, Oslakovic C, et al. (2010). Modeling the time evolution of the nanoparticle-protein corona in a body fluid. PLoS One 5:e10949.
   PubMed Web of Science ®Google Scholar
• Doloff JC, Veiseh O, Vegas AJ, et al. (2017). Colony stimulating factor-1 receptor is a central component of the foreign body response to biomaterial implants in rodents and non-human primates. Nat Mater 16:671–80.
   PubMed Web of Science ®Google Scholar
• Eliopoulos N, Stagg J, Lejeune L, et al. (2005). Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood 106:4057–65.
   PubMed Web of Science ®Google Scholar
• Follin B, Juhl M, Cohen S, et al. (2015). Human adipose-derived stromal cells in a clinically applicable injectable alginate hydrogel: phenotypic and immunomodulatory evaluation. Cytotherapy 17:1104–18.
   PubMed Web of Science ®Google Scholar
• Garate A, Ciriza J, Casado JG, et al. (2015). Assessment of the behavior of mesenchymal stem cells immobilized in biomimetic alginate microcapsules. Mol Pharmaceut 12:3953–62.
   PubMed Web of Science ®Google Scholar
• Gebler A, Zabel O, Seliger B. (2012). The immunomodulatory capacity of mesenchymal stem cells. Trends Mol Med 18:128–34.
   PubMed Web of Science ®Google Scholar
• Goenka S, Sant V, Sant S. (2013). Graphene-based nanomaterials for drug delivery and tissue engineering. J Control Release 173:75–88.
   PubMed Web of Science ®Google Scholar
• Gurruchaga H, Ciriza J, Saenz Del Burgo L, et al. (2015). Cryopreservation of microencapsulated murine mesenchymal stem cells genetically engineered to secrete erythropoietin. Int J Pharm 485:15–24.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Harb G, Rajotte RV, et al. (2006). Immune mechanisms associated with the rejection of encapsulated neonatal porcine islet xenografts. Xenotransplantation 13:547–59.
   PubMed Web of Science ®Google Scholar
• Kolb M, Bonniaud P, Galt T, et al. (2002). Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of "fibrosis-prone" and "fibrosis-resistant" mouse strains. Am J Respir Cell Mol Biol 27:141–50.
   PubMed Web of Science ®Google Scholar
• Lee KY, Mooney DJ. (2012). Alginate: properties and biomedical applications. Prog Polym Sci 37:106–26.
   PubMed Web of Science ®Google Scholar
• Lee WC, Lim CH, Shi H, et al. (2011). Origin of enhanced stem cell growth and differentiation on graphene and graphene oxide. ACS Nano 5:7334–41.
   PubMed Web of Science ®Google Scholar
• Li DW, Duncan ID. (1998). The immune status of the myelin deficient rat and its immune responses to transplanted allogeneic glial cells. J Neuroimmunol 85:202–11.
   PubMed Web of Science ®Google Scholar
• Lim F, Sun AM. (1980). Microencapsulated islets as bioartificial endocrine pancreas. Science 210:908–10.
   PubMed Web of Science ®Google Scholar
• Maccario R, Podesta M, Moretta A, et al. (2005). Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 90:516–25.
   PubMed Web of Science ®Google Scholar
• Meirelles Lda S, Fontes AM, Covas DT, et al. (2009). Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20:419–27.
   PubMed Web of Science ®Google Scholar
• Murua A, Orive G, Hernandez RM, et al. (2009). Xenogeneic transplantation of erythropoietin-secreting cells immobilized in microcapsules using transient immunosuppression. J Control Release 137:174–8.
   PubMed Web of Science ®Google Scholar
• Nauta AJ, Kruisselbrink AB, Lurvink E, et al. (2006). Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J Immunol 177:2080–7.
   PubMed Web of Science ®Google Scholar
• Orive G, De Castro M, Kong HJ, et al. (2009). Bioactive cell-hydrogel microcapsules for cell-based drug delivery. J Control Release 135:203–10.
   PubMed Web of Science ®Google Scholar
• Orive G, De Castro M, Ponce S, et al. (2005). Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules. Mol Ther 12:283–9.
   PubMed Web of Science ®Google Scholar
• Paredes-Juarez GA, De Haan BJ, Faas MM, et al. (2013). The role of pathogen-associated molecular patterns in inflammatory responses against alginate based microcapsules. J Control Release 172:983–92.
   PubMed Web of Science ®Google Scholar
• Prakash S, Jones ML. (2005). Artificial cell therapy: new strategies for the therapeutic delivery of live bacteria. J Biomed Biotechnol 2005:44–56.
   PubMedGoogle Scholar
• Rasmusson I. (2006). Immune modulation by mesenchymal stem cells. Exp Cell Res 312:2169–79.
   PubMed Web of Science ®Google Scholar
• Ratner BD. (2002). Reducing capsular thickness and enhancing angiogenesis around implant drug release systems. J Control Release 78:211–18.
   PubMed Web of Science ®Google Scholar
• Robitaille R, Pariseau JF, Leblond FA, et al. (1999). Studies on small (<350 microm) alginate-poly-L-lysine microcapsules. III. Biocompatibility of smaller versus standard microcapsules. J Biomed Mater Res 44:116–20.
   PubMed Web of Science ®Google Scholar
• Saenz Del Burgo L, Ciriza J, Acarregui A, et al. (2017). Hybrid alginate-protein-coated graphene oxide microcapsules enhance the functionality of erythropoietin secreting C2C12 myoblasts. Mol Pharmaceutics 14:885–98.
   PubMed Web of Science ®Google Scholar
• Sakai S, Kawakami K. (2010). Development of subsieve-size capsules and application to cell therapy. Adv Exp Med Biol 670:22–30.
   PubMed Web of Science ®Google Scholar
• Shi M, Liu ZW, Wang FS. (2011). Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol 164:1–8.
   PubMed Web of Science ®Google Scholar
• Stucky EC, Schloss RS, Yarmush ML, et al. (2015). Alginate micro-encapsulation of mesenchymal stromal cells enhances modulation of the neuro-inflammatory response. Cytotherapy 17:1353–64.
   PubMed Web of Science ®Google Scholar
• Sugiura S, Oda T, Aoyagi Y, et al. (2007). Microfabricated airflow nozzle for microencapsulation of living cells into 150 micrometer microcapsules. Biomed Microdevices 9:91–9.
   PubMed Web of Science ®Google Scholar
• Tam SK, Bilodeau S, Dusseault J, et al. (2011). Biocompatibility and physicochemical characteristics of alginate-polycation microcapsules. Acta Biomater 7:1683–92.
   PubMed Web of Science ®Google Scholar
• Tam SK, Dusseault J, Polizu S, et al. (2005). Physicochemical model of alginate-poly-L-lysine microcapsules defined at the micrometric/nanometric scale using ATR-FTIR, XPS, and ToF-SIMS. Biomaterials 26:6950–61.
   PubMed Web of Science ®Google Scholar
• Tambuyzer BR, Bergwerf I, De Vocht N, et al. (2009). Allogeneic stromal cell implantation in brain tissue leads to robust microglial activation. Immunol Cell Biol 87:267–73.
   PubMed Web of Science ®Google Scholar
• Uccelli A, Moretta L, Pistoia V. (2006). Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 36:2566–73.
   PubMed Web of Science ®Google Scholar
• Vegas AJ, Veiseh O, Doloff JC, et al. (2016). Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates. Nat Biotechnol 34:345–52.
   PubMed Web of Science ®Google Scholar
• Veiseh O, Doloff JC, Ma M, et al. (2015). Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates. Nature Mater 14:643–51.
   PubMed Web of Science ®Google Scholar
• Whelehan M, Marison IW. (2011). Microencapsulation using vibrating technology. J Microencapsul 28:669–88.
   PubMed Web of Science ®Google Scholar
• Williams DF. (2008). On the mechanisms of biocompatibility. Biomaterials 29:2941–53.
   PubMed Web of Science ®Google Scholar
• Wilson JT, Chaikof EL. (2008). Challenges and emerging technologies in the immunoisolation of cells and tissues. Adv Drug Deliv Rev 60:124–45.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ali SF, Dervishi E, et al. (2010). Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS Nano 4:3181–6.
   PubMed Web of Science ®Google Scholar